Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab
Clinical trial NCT05184179 · COMPLETED
Trial details
- NCT number
- NCT05184179
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-12-01
- Primary completion
- 2022-08-16
- Enrollment
- 5450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.